PetMed Express Q4 2024 GAAP EPS $(0.25) Misses $(0.07) Estimate, Sales $66.504M Beat $65.000M Estimate
Author: Benzinga Newsdesk | June 11, 2024 04:08pm
PetMed Express (NASDAQ:
PETS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.07) by 257.14 percent. This is a 2400 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $66.504 million which beat the analyst consensus estimate of $65.000 million by 2.31 percent. This is a 6.56 percent increase over sales of $62.407 million the same period last year.
Posted In: PETS